AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter— 510(k) K200206
Substantially EquivalentStryker Neurovascular
FDA 510(k) clearance K200206 for AXS Vecta 71 Intermediate Catheter, AXS Vecta 74 Intermediate Catheter, Substantially Equivalent on 2020-02-27. Applicant: Stryker Neurovascular.
Clearance details
- Applicant
- Stryker Neurovascular
- Product code
- Code QJP
- Advisory panel
- Cardiovascular
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Fremont, CA, US
Adverse events under product code QJP
product code QJP- Death
- 43
- Injury
- 233
- Malfunction
- 1,010
- Total
- 1,286
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.